# Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

> **NCT04011020** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Throne Biotechnologies Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **COMBINATION_PRODUCT:** Stem Cell Educator therapy

## Key facts

- **NCT ID:** NCT04011020
- **Lead sponsor:** Throne Biotechnologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-20
- **Primary completion:** 2024-10-20
- **Final completion:** 2025-06-20
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04011020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04011020, "Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04011020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*